Methes Energies International (MEIL) 10-Q 15 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Aug. 31, 2014	Oct. 15, 2014
Document And Entity Information	'	'
Entity Registrant Name	'METHES ENERGIES INTERNATIONAL LTD	'
Entity Central Index Key	'0001436549	'
Document Type	'10-Q	'
Document Period End Date	31-Aug-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--11-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	11,460,431
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Aug. 31, 2014	Nov. 30, 2013
Current assets	'	'
Cash and cash equivalents	$504,287	$174,084
Accounts receivable, net (notes 14 and 16)	662,877	1,154,916
Inventories (note 4)	850,732	801,063
Prepaid expenses and deposits (note 5)	84,252	84,990
Fair value of derivative instruments (note 3)	13,311	0
Deferred financing fees	0	49,139
Total current assets	2,115,459	2,264,192
Deposits and employee loans	27,058	30,398
Property, plant and equipment, net (note 6)	7,950,587	8,178,694
Intangible assets, net	377,862	393,015
Total assets	10,470,966	10,866,300
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Credit facility (note 11)	0	1,019,513
Accounts payable (note 14)	823,356	2,766,661
Accrued liabilities	378,778	211,296
Customer deposits (note 14)	152,186	8,185
Payable to related parties and others (note 7)	0	2,251,402
Short-term loans (note 8)	1,296,528	1,961,651
Total current	2,650,848	8,218,708
Non-current liabilities	'	'
Payable to related party (note 9)	759,010	0
Term loan (note 10)	1,752,415	0
Total non-current liabilities	2,511,425	0
Total liabilities	5,162,273	8,218,708
Stockholders' equity	'	'
Preferred stock, $0.001 par value, 10,000,000 shares authorized; 260,782 and 111,822 shares issued and outstanding as at November 30, 2013 and August 31, 2014, respectively (note 12)	112	261
Common stock, $0.001 par value, 75,000,000 shares authorized; 7,231,417 and 11,460,431 shares issued and outstanding at November 30, 2013 and August 31, 2014, respectively (note 12)	11,459	7,231
Additional paid-in capital	26,285,441	18,532,803
Accumulated deficit	-20,988,319	-15,892,703
Total stockholders' equity	5,308,693	2,647,592
Total liabilities and stockholders' equity	$10,470,966	$10,866,300

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Aug. 31, 2014	Nov. 30, 2013
Stockholders' equity	'	'
Preferred stock par value	$0.00	$0.00
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock shares issued	111,822	260,782
Preferred stock shares outstanding	111,822	260,782
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	11,460,431	7,231,417
Common stock, shares outstanding	11,460,431	7,231,417

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013
Revenue	'	'	'	'
Biodiesel sales	$2,115,715	$1,528,152	$2,741,546	$3,738,892
Feedstock sales	52,310	52,104	148,651	137,092
Glycerin sales	33,671	30,074	57,517	66,515
Government incentives (note 16)	179,594	90,470	218,185	269,474
Equipment and part sales	0	3,112	1,397	5,769
Royalties	8,096	11,146	19,550	17,921
Others	11,261	32,146	31,682	50,006
Revenue, Total	2,400,647	1,747,204	3,218,528	4,285,669
Cost of goods sold (note 3)	2,833,008	1,574,344	3,497,547	3,985,057
Gross profit	-432,361	172,860	-279,019	300,612
Operating expenses	'	'	'	'
Selling, general and administrative expenses (notes 6, 12 and 13)	1,501,875	1,366,084	4,409,575	4,134,010
Loss before interest and income taxes	-1,934,236	-1,193,224	-4,688,594	-3,833,398
Other (expenses)	'	'	'	'
Interest expense (note 18)	-96,858	-126,832	-390,933	-369,801
Interest income	0	308	147	308
Net loss before income taxes	-2,031,094	-1,319,748	-5,079,380	-4,202,891
Income taxes	0	0	0	0
Net loss for the period	($2,031,094)	($1,319,748)	($5,079,380)	($4,202,891)
Net Loss Per Common Share - Basic and Diluted	($0.18)	($0.19)	($0.54)	($0.61)
Weighted average number of common shares - Basic and Diluted	11,443,673	6,981,854	9,436,267	6,854,869

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (USD $)	Common Stock	Preferred Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning Balance, Amount at Nov. 30, 2012	$6,553	'	$16,033,123	($10,241,029)	$5,798,647
Beginning Balance, Shares at Nov. 30, 2012	6,553,169	'	'	'	'
Issuance of units under private placement, Shares	653,248	'	'	'	'
Issuance of units under private placement, Amount	653	'	2,149,347	'	2,150,000
Issuance cost common stock units under private placement	'	'	-368,611	'	-368,611
Issuance of Common stock for services, Shares	25,000	'	'	'	'
Issuance of Common stock for services, Amount	25	'	51,975	'	52,000
Issuance of preferred stock units under private placements, Share	'	260,782	'	'	'
Issuance of preferred stock units under private placements, Amount	'	261	622,239	'	622,500
Issuance cost - preferred stock under private placement	'	'	-149,330	'	-149,330
Stock based compensation	'	'	155,578	'	155,578
Dividends payable on preferred stock units	'	'	'	-9	-9
Issuance of common stock options to employees and officer	'	'	38,482	'	38,482
Net loss for the period	'	'	'	-5,651,665	-5,651,665
Ending Balance, Amount at Nov. 30, 2013	7,231	261	18,532,803	-15,892,703	2,647,592
Ending Balance, Shares at Nov. 30, 2013	7,231,417	260,782	'	'	'
Issuance of units under private placement, Shares	1,081,161	'	'	'	'
Issuance of units under private placement, Amount	1,081	'	2,161,240	'	2,162,321
Issuance of common stock under public offering, Shares	2,800,000	'	'	'	'
Issuance of common stock under public offering, Amount	2,800	'	5,597,200	'	5,600,000
Issuance cost common stock units under private placement	'	'	-949,358	'	-949,358
Issuance of common stock units for cash, Shares	16,129	'	'	'	'
Issuance of common stock units for cash, Amount	16	'	99,984	'	100,000
Issuance of common stock units for cash upon conversion of preferred stock units, Shares	148,960	-148,960	'	'	'
Issuance of common stock units for cash upon conversion of preferred stock units, Amount	149	-149	'	'	'
Issuance of common stock upon conversion of dividends on preferred stock, Shares	7,205	'	'	'	'
Issuance of common stock upon conversion of dividends on preferred stock, Amount	7	'	16,229	-16,236	'
Issuance of Common stock for services, Shares	133,871	'	'	'	'
Issuance of Common stock for services, Amount	134	'	489,616	'	489,750
Issuance of common stock units for loan settlement, Shares	34,688	'	'	'	'
Issuance of common stock units for loan settlement, Amount	34	'	127,965	'	127,999
Issuance of common stock upon conversion of placement agent warrants, Shares	7,000	'	'	'	'
Issuance of common stock upon conversion of placement agent warrants, Amount	7	'	13,993	'	14,000
Stock based compensation	'	'	195,769	'	195,769
Net loss for the period	'	'	'	-5,079,380	-5,079,380
Ending Balance, Amount at Aug. 31, 2014	$11,459	$112	$26,285,441	($20,988,319)	$5,308,693
Ending Balance, Shares at Aug. 31, 2014	11,460,431	111,822	'	'	'

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013
Cash flow from operating activities:	'	'
Net loss for the period	($5,079,380)	($4,202,891)
Adjustments to reconcile net loss to net cash used in operations	'	'
Depreciation and amortization	333,287	353,488
Stock-based compensation	195,769	138,139
Unrealized foreign exchange gain	-49,209	-104,633
Deferred financing fees amortization	49,139	30,590
Accrued interest	127,118	117,506
Bad debts	35,662	25,970
Issuance of common stock/units for consulting services	459,337	0
Unrealized loss on call options (note 3)	11,169	0
Changes in operating assets and liabilities:	'	'
Accounts receivable	456,377	64,251
Inventories	-49,670	336,445
Prepaid expenses and deposits	31,153	27,597
Accounts payable and accrued liabilities	-1,775,824	1,101,981
Customer deposits	144,002	115,341
Deposits and employee loans	3,340	0
Net cash used in operating activities	-5,107,730	-1,996,216
Cash flows from investing activities:	'	'
Additions to property, plant and equipment	-90,027	-378,868
Additions to intangible assets	0	-191
Purchase of call options (note 3)	-24,480	0
Net cash used in investing activities	114,507	379,059
Cash flows from financing activities:	'	'
Advances from (repayment of) credit facility	-1,019,513	129,895
Advances from short-term loans	0	1,938,040
Repayments of short term loans	-493,175	-1,444,350
Advances from long-term related party loans	172,000	0
Advances from related parties and others	0	519,258
Repayments to related parties and others	-33,835	-33,835
Deferred financing fees	0	-51,075
Issuance of common stock/units under private placement	2,162,321	1,750,000
Issuance costs - common stock units under private placement	-949,358	-330,611
Issuance of common stock under public offering	5,600,000	0
Issuance of common stock/units for cash	100,000	0
Issuance of common stock upon conversion of placement agent warrants	14,000	0
Net cash provided by financing activities	5,552,440	2,477,322
NET INCREASE IN CASH AND CASH EQUIVALENTS	330,203	102,047
Cash and cash equivalents, beginning of period	174,084	402,724
CASH AND CASH EQUIVALENTS, END OF PERIOD	504,287	504,771
Supplemental disclosures of cash flow information, cash paid:	'	'
Interest paid	255,212	238,206
Common shares issued as repayment of loan	$128,000	$0

1_NATURE_OF_THE_BUSINESS_FINAN

1. NATURE OF THE BUSINESS, FINANCING REQUIREMENTS AND BASIS OF PRESENTATION	9 Months Ended
	Aug. 31, 2014
Accounting Policies [Abstract]	'
1. NATURE OF THE BUSINESS, FINANCING REQUIREMENTS AND BASIS OF PRESENTATION	'
	Methes Energies International Ltd. ("Methes" or the "Company"), was incorporated on June 27, 2007 in the State of Nevada. Methes, through its operations in Canada and the United States, is a biodiesel processing equipment provider and a biodiesel producer. The Company has developed biodiesel processing equipment to produce biodiesel from recycled oils and virgin oils. The Company, through its wholly-owned subsidiary Methes Energies Canada Inc. ("Methes Canada"), owns two biodiesel manufacturing facilities; one is located in Mississauga, Ontario with a nameplate production capacity of 1.3 million gallons per year (mgy), which is currently idle, and the second facility is capable of producing 13.0 mgy of biodiesel located in Sombra, Ontario. In addition to Methes Canada, Methes Energies USA Ltd. ("Methes USA") was incorporated as the wholly-owned subsidiary of the Company on June 27, 2007. All references in this Form 10-Q to “Company,” “Methes,” “we,” “us,” or “our” refer to Methes Energies International Ltd. and its wholly owned subsidiaries Methes Canada and Methes USA unless the context otherwise indicates.
	As at August 31, 2014, due in large part to the funds spent to develop, build and commission our Sombra facility as well as minimal sales of biodiesel, the Company had a working capital deficiency of $535,389. During the nine months ended August 31, 2014, the Company incurred a loss of $5,079,380 and had negative cash flows from operations of $5,107,730. The Company anticipates that its Sombra facility will generate positive cash flows from operations and will operate profitably once full-scale commercial operations are achieved. In order to meet its development goals and ongoing operational requirements, the Company may require additional financing in the next 12 months. However, management believes that the anticipated positive cash flows from operations, the cash flow from the potential sale of biodiesel equipment, and the cash flow from the additional financing completed in August 2014 and the anticipated additional financing will be sufficient to meet the Company’s cash requirements for at least the next 12 months.
	The condensed consolidated financial statements have been prepared by the Company without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted as permitted by such rules and regulations. All adjustments, consisting of normal recurring adjustments, have been included. Management believes that the disclosures are adequate to present fairly the financial position, results of operations and cash flows at the dates and for the periods presented. It is suggested that these interim financial statements be read in conjunction with the consolidated financial statements and the notes thereto appearing in the Company’s latest annual report on Form 10-K. Results for interim periods are not necessarily indicative of those to be expected for the full fiscal year.

2_SUMMARY_OF_SIGNIFICANT_ACCOU

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Aug. 31, 2014
Accounting Policies [Abstract]	'
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	Basis of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA.  All significant inter-company transactions and balances have been eliminated.
	Deferred Financing Fees
	Financing fees relating to other financing arrangements are deferred and amortized over the term of the respective loan.
	Shipping and Handling Costs
	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 "Cost of Sales and Services". Shipping and handling costs for the three and nine months ended August 31, 2014 were $96,362 and $119,965, respectively (three and nine months ended August 31, 2013 was $23,869 and $199,125, respectively). Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
	Income Taxes and Uncertain Tax Positions
	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. The Company assesses the validity of conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause the Company to change their judgment regarding the likelihood of a tax position's sustainability under audit. The Company has determined that there were no material uncertain tax positions as at November 30, 2013 and August 31, 2014.
	Per Share Data
	Basic earnings per share ("EPS") is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 2,192,012 warrants and 365,057 Common Stock options issued and outstanding as at August 31, 2013 and 3,923,149 warrants, 445,071 Common Stock options and 111,822 shares of Preferred Stock issued and outstanding as at August 31, 2014. All outstanding warrants, preferred shares and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the diluted loss per share calculation for the three and nine months ended August 31, 2013 and August 31, 2014.
	Renewable Identification Numbers (RINs)
	When the Company imports and sells a gallon of biodiesel into United States, 1.5 RINs per gallon are generated. RINs are used to track compliance with Renewable Fuel Standards (RFS2). RFS2 allows the Company to attach between zero and 2.5 RINs to any gallon of biodiesel. When the Company imports and sells a gallon of biodiesel, 1.5 RINs are generally attached. As a result, a portion of the selling price for a gallon of biodiesel is generally attributable to RFS2 compliance. However, RINs that the Company generates are a form of government incentive and not a result of the physical attributes of the biodiesel production. Therefore, no cost is allocated to the RIN when it is generated, regardless of whether the RIN is transferred with the biodiesel produced or held by the Company pending attachment to other biodiesel production sales.
	The Company may, however, obtain RINs returned from its customers as part of the biodiesel sales terms after having separated the RINs from gallons of biomass-based diesel. From time to time, the Company holds varying amounts of these separated RINs for resale. RINs obtained from customers are initially recorded at fair value on the date received, and are subsequently revalued at fair value as of the last day of each accounting period. Fair value adjustments are reflected in costs of goods sold for the period. The value of RINs obtained from customers are reflected in “Inventories” on the consolidated balance sheet.
	Derivative Instruments
	Derivatives are recorded on the balance sheet at fair value with changes in fair value recognized in current period earnings. The Company accounts for derivative instruments under ASC Topic 815 - 40, “Derivatives and Hedging” or ASC 815 - 40. Under these standards, derivative instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair value. The Company utilizes futures contracts and options to hedge feedstock purchases. The Company has designated the derivatives as non-hedge derivatives that are utilized to manage cash flow. Unrealized gains and losses on the futures contracts and options are therefore recognized as a component of biodiesel cost of goods sold, and are reflected in current results of operations.
	New Accounting Pronouncements
	In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities (Topic 210). The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The disclosures required by the amendments are required to be applied retrospectively for all comparative periods presented. The Company adopted this statement effective December 1, 2013. The adoption of this statement did not have a material effect on the Company’s unaudited condensed consolidated financial statements.
	On May 28, 2014, the FASB issued a new financial accounting standard on revenue from contracts with customers, Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard.
	On August 27, 2014, the FASB issued a new financial accounting standard on going concern, Update 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The standard provides guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern. The amendments in this Update apply to all companies. They become effective in the annual period ending after December 15, 2016, with early application permitted. The Company is currently evaluating the impact of this accounting standard.
	All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the condensed consolidated financial statements of the Company.

3_FAIR_VALUE_OF_DERIVATIVE_INS

3. FAIR VALUE OF DERIVATIVE INSTRUMENTS	9 Months Ended
	Aug. 31, 2014
Investments, All Other Investments [Abstract]	'
3. FAIR VALUE OF DERIVATIVE INSTRUMENTS	'
	Fair value of derivative instruments represent the fair value of the outstanding call option contracts to hedge the Company’s exposure to price risk related to feedstock oil to be purchased in September 2014. These call options were purchased for a cost of $24,480. The fair value loss of $11,169 (three months ended August 31, 2013, $nil) was recorded as part of the cost of goods sold during the quarter.
	During the quarter, the Company has entered into certain derivative contracts to hedge its exposure to price risk related to feedstock oil. The Company recorded realized losses of $245,346 (three months ended August 31, 2013, $ nil) as part of cost of goods sold upon settlement of these contracts during the quarter, however, the Company acquired the feedstock oil at a lower prices providing a better margin overall.  As at August 31, 2014, no derivative futures contracts were outstanding.

4_INVENTORIES

4. INVENTORIES	9 Months Ended
	Aug. 31, 2014
Inventory Disclosure [Abstract]	'
4. INVENTORIES	'
	Inventories consisted of the following:
		As at		As at
		November 30,		August 31,
		2013		2014
	Raw materials	$	345,049	$	194,974
	Finished goods		444,648		541,558
	Equipment		11,366		11,366
	K2 RINs		—		102,834
		$	801,063	$	850,732
	K2 Renewable Identification Numbers are separated RINs that the Company intends to sell in the open market subsequent to the quarter end.  K2 RINs were valued at market price of $0.51 per gallon.

5_PREPAID_EXPENSES_AND_DEPOSIT

5. PREPAID EXPENSES AND DEPOSITS	9 Months Ended
	Aug. 31, 2014
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
5. PREPAID EXPENSES AND DEPOSITS	'
	Prepaid expenses and deposits includes investor relations consulting services amounting to $30,413 as at August 31, 2014 (as at November 30, 2013, $44,652) which were paid through issuance of shares of Common Stock of the Company.

6_PROPERTY_PLANT_AND_EQUIPMENT

6. PROPERTY, PLANT AND EQUIPMENT	9 Months Ended
	Aug. 31, 2014
Property, Plant and Equipment [Abstract]	'
6. PROPERTY, PLANT AND EQUIPMENT	'
		As at August 31, 2014						As at
								November 30,
								2013
		Cost		Accumulated		Net Book		Net Book
				Depreciation		Value		Value
	Sombra site:
	Land	$	409,134	$	—	$	409,134	$	409,134
	Building		2,944,356		297,116		2,647,240		2,702,446
	Equipment		775,865		465,848		310,017		390,465
	Equipment - Denami 3000		4,254,995		316,489		3,938,506		3,975,441
	Computer equipment		11,835		10,282		1,553		5,918
	Vehicle		11,622		1,162		10,460		11,331
	Mississauga site:
	Computer equipment		23,464		23,403		61		1,316
	Leasehold improvements		102,201		63,403		38,798		46,591
	Equipment and fixtures		255,463		197,434		58,029		77,662
	Equipment - Denami 600		720,042		183,253		536,789		558,390
		$	9,508,977	$	1,558,390	$	7,950,587	$	8,178,694
	Total depreciation expense included in selling, general and administrative expenses in the unaudited consolidated statements of operations related to property, plant and equipment for the three and nine months ended August 31, 2014 was $106,039 and $318,134, respectively (three and nine months ended August 31, 2013 was $104,743 and $338,335, respectively).

7_PAYABLE_TO_RELATED_PARTIES_A

7. PAYABLE TO RELATED PARTIES AND OTHERS	9 Months Ended
	Aug. 31, 2014
Related Party Transactions [Abstract]	'
7. PAYABLE TO RELATED PARTIES AND OTHERS	'
	Payable to related parties is comprised of the following:
		As at		As at
		November 30,		August 31,
		2013		2014
	Michel G. Laporte (stockholder and Director)  (reclassified to non-current, see note 9)	$	719,230	$	—
	Due to an unrelated corporation (reclassified to non-current, see note 10)		1,495,477		—
	Other loan		36,695		—
		$	2,251,402	$	—

8_SHORTTERM_LOANS

8. SHORT-TERM LOANS	9 Months Ended
	Aug. 31, 2014
Debt Disclosure [Abstract]	'
8. SHORT TERM LOAN	'
			As at		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
			November 30,								August 31,
			2013								2014
	Term loan (July 2013)		$	1,506,560	$	—	$	-227,875	$	-37,090	$	1,241,595
	Promissory note (i)			52,533		2,400		—		—		54,933
	Promissory note (ii)			402,558		4,099		-397,400		-9,257		—
			$	1,961,651	$	6,499	$	-625,275	$	-46,347	$	1,296,528
	Term loan (July 2013)
	On July 12, 2013, Methes Canada entered into a term loan facility agreement with a lender (the “Agreement”) pursuant to which Methes Canada is able to borrow up to $1,540,640 ($1,600,000 CAD) for a term of 12 months at an interest rate of 12% per annum (the “July 2013 Facility”). Under the terms of the Agreement, interest is payable monthly and outstanding principal is due at maturity. Outstanding principal would be prepayable after six months upon 30 days’ notice and payment of a penalty equal to one-month's interest. The July 2013 Facility is collateralized by a security agreement from Methes Canada on certain of its assets except for accounts receivable and inventory and a first collateral mortgage on its real property located at Sombra, Ontario.  The July 2013 Facility prohibits payment of debt owed by the Company to certain of its stockholders, a director and an unrelated Corporation (see note 10) during the life of the facility and contains other customary debt covenants.
	Interest expense incurred during the three and nine months ended August 31, 2014 was $44,250 and $131,818 (three and nine months ended August 31, 2013 - $25,001 and $25,001).
	A partial payment of $227,875 was made during the current quarter against the principal outstanding on the July 2013 Facility.
	Subsequent to quarter end, Methes Canada signed a term sheet with a new lender for a mortgage loan of $1,700,000 (see note 19). The proceeds from that loan will be used to repay the remaining balance on the July 2013 Facility.
	The one year term loan agreement (December 2013) for $1,834,200 bearing interest at 9% per annum was cancelled during the quarter ended August 31, 2014.  The monies advanced from this loan of $140,743 including interest was reclassified and set up as deposit on the potential sale of biodiesel equipment.
	Promissory Notes:
	(i)		In January 2010, the Company borrowed $40,000 from a lender and issued to the lender a demand promissory note in the principal amount of $40,000 bearing interest at 8% per annum.  Repayment of the loan and payment of the accrued interest is due upon demand.
			Interest expense incurred during the three and nine months ended August 31, 2014 was $800 and $2,400 (three and nine months ended August 31, 2013 - $800 and $2,400).
	(ii)		On January 26, 2013, the Company borrowed $397,400 ($400,000 CAD) from a lender and issued to the lender a demand promissory note in the principal amount of $397,400 bearing interest at 8% per annum (the "January 2013 Note"). Repayment of the loan and payment of the accrued interest is due upon demand.
			During the nine months ended August 31, 2014, the January 2013 Note was repaid in full, which included total principal and interest payments of $397,400 ($400,000 CAD) and $32,571 ($34,057 CAD), respectively, as follows:
	-	On January 17, 2014, the Company converted $128,000 of the outstanding principal due on the January 2013 Note into 34,688 shares of Common Stock based at the closing market price of $3.69 per share of Common Stock on January 17, 2014 (refer to note 12 under section “Issuance of Common Stock for loan settlement”).
	-	On January 30, 2014, the Company paid $153,871 against the outstanding principal balance through borrowing a note payable from another lender.
	-	On May 30, 2014, the Company paid the remaining balance.
	Interest expense incurred during the three and nine months ended August 31, 2014 was $1,569 and $4,099 (three and nine months ended August 31, 2013 - $7,720 and $18,296).

9_PAYABLE_TO_RELATED_PARTY

9. PAYABLE TO RELATED PARTY	9 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
9. PAYABLE TO RELATED PARTY	'
	Payable to related party includes promissory notes due to Michel Laporte, a stockholder and director of the Company.  The promissory notes bear interest at 8% per annum, are unsecured and not payable until April 1, 2016.
	The principal amount outstanding as at August 31, 2014 is $663,000 and total accrued interest includes $96,010 (as at November 30, 2013, principal of $663,000 and interest of $56,230).
	Interest expense incurred during the three and nine months ended August 31, 2014 was $13,260 and $39,780 (three and nine months ended August 31, 2013 - $12,000 and $21,131).

10_TERM_LOAN

10. TERM LOAN	9 Months Ended
	Aug. 31, 2014
Debt Disclosure [Abstract]	'
10. TERM LOAN	'
	Term loan includes promissory notes due to an unrelated Corporation.  The promissory notes bear interest at 8% per annum, are unsecured and not due for payment until April 1, 2016.
	The principal amount outstanding as at August 31, 2014 is $1,452,000 and total accrued interest includes $300,415 (as at November 30, 2013, principal of $1,280,000 and total interest of $215,477).
	Interest expense incurred during the three and nine months ended August 31, 2014 was $29,040 and $84,938 (three and nine months ended August 31, 2013 - $25,600 and $73,600).

11_CREDIT_FACILITY

11. CREDIT FACILITY	9 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
11. CREDIT FACILITY	'
	Credit Facility No.1
	On August 16, 2013, Methes Canada entered into and closed on a working capital loan facility from a Toronto, Ontario lending firm (the “Working Capital Facility”). Under the Working Capital Facility, Methes Canada may borrow up to $1,500,000 for its Sombra, Ontario biodiesel manufacturing plant, of which up to $750,000 may be from cash advances against Methes Canada’s accounts receivables through factoring of accounts receivable with full recourse and up to an additional $750,000 in cash advances for use exclusively to purchase feedstock for the production of biodiesel. The Working Capital Facility is secured by a pledge of the accounts receivable and inventory of Methes Canada and Methes USA.
	In connection with all borrowings to purchase feedstock, Methes Canada issued a promissory note to the lender bearing a per annum interest rate equal to the Bank of Montreal Prime Rate plus sixteen percent (16%) and is due and payable upon the earlier of demand or August 13, 2014. The effective interest rate as of August 31, 2014 was 19% (16% plus 3% prime rate).  Under the terms of the promissory note, interest only is payable monthly on the last business day of each calendar month.
	Cash advances against accounts receivables are based on the amount of the receivables net of a purchase discount as agreed with the lender with an interest rate of Bank of Montreal Prime Rate plus three percent (3%).  Effective interest rate as of August 31, 2014 was 6% (3% plus 3% prime rate). The balance outstanding as at November 30, 2013 of $1,019,513 was fully repaid during the first quarter of fiscal 2014 through cash from operations.
	Interest expense incurred under this credit facility during the three and nine months ended August 31, 2014 was $nil and $7,909 (three and nine months ended August 31, 2013 - $nil and $nil).
	During the quarter ended August 31, 2014, the Working Capital Facility was discontinued and replaced with Credit Facility No. 2 (see below).
	Credit Facility No.2
	On August 28, 2014, the Company entered into a feedstock credit facility with a major provider of credit to the renewable fuels industry (the “Lender”), which will provide the Company all the feedstock that is required to run at full current capacity and allow the Company to fulfill future orders for biodiesel that it receives from its customers that have been approved by the credit department of the Lender.  The Company had also agreed to a biodiesel sales contract subject to the Lender’s approval and subject to a tripartite payment and Assignment Agreement.  The facility bears interest at 5% per annum.
	As referred to in note 3, the Company has also entered into certain derivative contracts with the Lender to hedge its exposure to price risk related to feedstock oil.

12_STOCKHOLDERS_EQUITY

12. STOCKHOLDERS' EQUITY	9 Months Ended
	Aug. 31, 2014
Equity [Abstract]	'
12. STOCKHOLDERS' EQUITY	'
	COMMON STOCK
	The Company is authorized to issue 75,000,000 shares of Common Stock with a par value of $0.001 and had 7,231,417 and 11,460,431 shares of Common Stock issued and outstanding as of November 30, 2013 and August 31, 2014, respectively.
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2013			7,231,417
	Issuance of shares under private placement			1,081,161		$	2
	Issuance of shares under public offering			2,800,000		$	2
	Issuance of shares upon conversion of Preferred Stocks units			148,960		$	2.26
	Issuance of shares upon conversion of accrued dividends on Preferred Stocks units			7,205		$	2.26
	Issuance of shares for cash			16,129		See below
	Issuance of shares for services			133,871		See below
	Issuance of shares for loan settlement			34,688		$	3.69
	Issuance of shares upon conversion of Placement Agent Warrant			7,000		$	2
	Balance as at August 31, 2014			11,460,431
	Issuance of Common Stock units under Private Placement
	During the month of December 2013 the Company issued a total of 1,081,161 units (each a “Unit”) to accredited investors at a price of $2.00 per Unit under a private placement and raised net proceeds of approximately $1.87 million, after deducting the sales commission and fees (the “December 2013 Private Placement”). Each Unit consists of one share of Common Stock and one five year Common Stock Warrant to purchase one share of Common Stock at an exercise price of $4.00 per share (“Common Stock Warrant”). (see Stock Warrant Table below).
	In connection with the December 2013 Private Placement, the Company issued compensatory warrants (the “Placement Agent Warrant”) to the Placement Agents for the offering exercisable for an aggregate of 108,116 Units.  Each of these warrants is exercisable to acquire a Unit at an exercise price of $2.00 per Unit.  The fair value of these warrants at the grant date was $257,553.  This amount was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates between 1.66% and 1.74%, a dividend yield of 0%, and an expected volatility of 75%. (see Stock Warrant Table below).
	Issuance of Common Stocks under Public Offering
	On May 27, 2014, the Company closed an underwritten public offering of 2,500,000 shares of Common Stock and raised net proceeds of $4.5 million, after deducting Underwriter’s fees and estimated offering expenses. Under the terms of the Underwriting Agreement, the Underwriter had an option through June 26, 2014, to purchase up to an additional 375,000 shares of Common Stock under the same terms as the public offering to cover over-allotments (the “Over-Allotment Option”), if any.
	On May 28, 2014, the Underwriter partially exercised the Over-Allotment Option for 300,000 shares of Common Stock raising approximately $550,000 of additional net proceeds for the Company.
	Issuance of Common Stocks upon conversion of Preferred Stocks units and accrued dividends
	i)	Series A-2 Preferred Stock Conversions
	On March 13, 2014, two holders of our Series A-2 Convertible Preferred Stock (“Series A-2 Preferred”) converted 20,876 shares of outstanding Series A-2 Preferred including with an aggregate stated value of approximately $49,139 (including accrued dividends of $1,750 or 772 stocks) into 21,648 shares of Common Stock at a price of $2.27 per share.
	On May 9, 2014, a holder of our Series A-2 Preferred converted 10,438 shares of outstanding Series A-2 Preferred with an aggregate stated value of approximately $26,250 (including accrued dividends of $1,250 or 551 stocks) into 10,989 shares of Common Stock at a price of $2.27 per share.
	ii)	Series A-1 Preferred Stock Conversions
	On March 17, 2014, two holders of our Series A-1 Convertible Preferred Stock (“Series A-1 Preferred”) converted 117,646 shares of outstanding Series A-1 Preferred with an aggregate stated value of approximately $293,235 (including accrued dividends of $13,235 or 5,882 stocks) into 123,528 shares of Common Stock at a price of $2.25 per share.
	Issuance of Common Stock for cash and services rendered
	On January 3, 2014, the Company issued 25,000 shares of Common Stock in the second installment quarterly payment of consulting fees for services to be rendered by a consultant for over a year which were valued at $87,250, based on the closing market price of $3.49 per share on the day of issuance.  On May 1, 2014, the Company issued 25,000 shares of Common Stock in the third quarterly installment payment of consulting fees for services to be rendered by the consultant which were valued at $61,250, based on the closing market price of $2.45 per share on the date of issuance.
	On January 10, 2014, the Company sold 50,000 Units to an accredited investor in a private placement for a purchase price of $125,000 (or $2.50 per Unit) of which $100,000 was paid in cash and $25,000 was settled through services rendered to the Company, which was included in the selling, general and administrative expenses. The aggregate fair value of the Units sold in this offering was $310,000 (or $6.20 per Unit), based on the closing market price of $3.58 per share of Common Stock on the day of issuance, and the fair value of the Common Stock Warrants of $2.62 per warrant.  The Common Stocks allocated to cash portion was 16,129 Common Stocks ($100,000/$310,000 x 50,000 units) and the services portion allocated is 33,871 Common Stocks.  The fair value of the Common Stock Warrants was estimated using the Black-Scholes option pricing model with an expected life of 5 years, risk free interest rates of 1.64%, a dividend yield of 0%, and an expected volatility of 100%.  The excess of the estimated fair value over the purchase price in the amount of $185,000 is included in the selling, general and administrative expenses. (see Stock Warrant Table below).
	On January 28, 2014, the Company issued 25,000 shares of Common Stock in payment of consulting fees for services to be rendered by a consulting corporation for a term of six months.  These shares of Common Stock were valued at $88,750, based on the closing market price of $3.55 per share on the date of issuance.
	On August 1, 2014, the Company issued 25,000 shares of Common Stock in the final quarterly installment payment of consulting fees for services to be rendered by the consultant which were valued at $42,500, based on the closing market price of $1.70 per share on the date of issuance, of which $30,413 is included in prepaid expenses as at August 31, 2014 (see note 5).
	Issuance of Common Stock for loan settlement
	On January 17, 2014, the Company issued 34,688 shares of Common Stock to a note holder at $3.69 per share of Common Stock in conversion of $128,000 of a note payable by the Company (See note 8(ii)).
	Issuance of Common Stocks upon conversion of Placement Agent Warrants
	On May 9 and 19, 2014, two holders of Placement Agent Warrants exercised their warrants for an aggregate of 7,000 Units at a price of $2.00 per Unit or an aggregate stated value of $14,000, which included 7,000 shares of Common Stock and 7,000 Warrants (each at an exercise price of $4.00).
	PREFERRED STOCK
	The Company is also authorized to issue up to 10,000,000 shares of preferred stock with a par value of $0.001 per share, from time to time in one or more series, without shareholder approval, when authorized by its board of directors (the “Board”).  As of each of November 30, 2013 and August 31, 2014, the Board has designated 152,519 shares of Series A-1 Preferred and 134,341 shares of Series A-2 Preferred.  As of November 30, 2013, 138,654 shares of Series A-1 Preferred and 122,128 shares of Series A-2 Preferred were issued and outstanding (for a total of 260,782 shares outstanding as of November 30, 2013).  During the nine months ended August 31, 2014, 117,646 shares of Series A-1 Preferred and 31,314 shares of Series A-2 Preferred were converted into shares of Common Stock.  As of August 31, 2014, 21,008 shares of Series A-1 Preferred and 90,814 shares of Series A-2 Preferred were issued and outstanding (for a total of 111,822 shares outstanding as of August 31, 2014).  Collectively, the Series A-1 Preferred and the Series A-2 Preferred are referred to herein as the “Series A Preferred Stock.”
	As at August 31, 2014, on the Series A Preferred Stock had total accumulated dividends of $23,004, none of which have been declared by the Board or accrued (August 31, 2013 - $nil).
	STOCK WARRANT TABLE:
		Grant Date		Exercise Period	No of Warrants			Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2013					2,678,872
	Common Stock Warrants issued – Private Placement	Dec. 20, 2013		5 years from grant date		1,081,161		$	4
	Placement Agent Warrant – Private Placement	Dec. 20 2013		5 years from grant date		108,116		$	2	$	257,553
	Placement Agent Warrant – Private Placement (November 27, 2013)	Dec. 20 2013		5 years from grant date		5,000		$	2	$	6,403
	Common Stock Warrant issued-accredited investor	Jan. 10, 2014		5 years from grant date		50,000		$	4
	Placement Agent Warrant exercise					-7,000		$	2
	Common Stock Warrant issued upon exercise of Placement Agent Warrant	May 9 and 14, 2014				7,000		$	4
				Dec. 20, 2018
	Balance as at August 31, 2014					3,923,149

13_STOCKBASED_COMPENSATION

13. STOCK-BASED COMPENSATION	9 Months Ended
	Aug. 31, 2014
Equity [Abstract]	'
13. STOCK-BASED COMPENSATION	'
	The Company's Amended and Restated the 2008 Directors, Officers and Employees Stock Option Plan, which was originally approved by the stockholders at the annual general meeting of the Company held on December 5, 2007, and subsequently amended by the stockholders on July 23, 2008. This plan was established to enable the Company to attract and retain the services of highly qualified and experienced directors, officers, employees and consultants and to give such persons an interest in the success of the Company and its subsidiaries. The total number of shares currently authorized under the plan is 391,134. The options and awards will be granted at the discretion of the Board of Directors. Options issued under the plan that are deemed to be incentive stock options will be priced at not less than 100% of the fair market value of the common shares at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model. There were no options granted during the nine months ended August 31, 2013 and 2014.
	All the grants vest quarterly over a two year period and expire on the tenth anniversary of the grant date. The following table summarizes the stock option activities of the Company.
		Number of options
	Outstanding as of November 30, 2012		383,310
	Granted		10,000
	Exercised		—
	Cancelled/forfeited		-27,379
	Outstanding as of November 30, 2013		365,931
	Granted		—
	Exercised		—
	Cancelled/forfeited		-20,860
	Outstanding as of August 31, 2014		345,071
	The stock-based compensation for the three and nine months ended August 31, 2014 was $2,051 and $9,747 (three and nine months ended August 31, 2013 - $9,870 and $76,502). The Company recorded this in selling, general and administrative expenses with the corresponding credit to additional paid-in capital.
	As of November 30, 2013 the Company has a total of 365,931 options outstanding to purchase Common Stock held by employees, directors and advisory board members, of which 353,922 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of November 30, 2013, the total fair value of the options granted to employees at the respective grant dates was $1,476,973, of which the unrecognized portion of $13,088 related to the unvested shares associated with these stock option grants will be recognized over a period of two years.
	As of August 31, 2014 the Company has a total of 345,071 options outstanding to purchase Common Stock held by employees, directors and advisory board members, of which 340,071 are vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of August 31, 2014, the total fair value of the options granted to employees at the respective grant dates was $1,476,973, of which the unrecognized portion of $3,341 related to the unvested shares associated with these stock option grants will be recognized over a period of 15 months.
	2012 Option Plan:
	Under the Company’s 2012 Directors, Officers and Employees Stock Option Plan (the “2012 Plan”), the Company granted a total of 100,000 options to purchase Common Stock to its four independent directors and chief financial officer on April 2, 2013.  The total number of shares currently authorized under the plan is 400,000.  The options and awards will be granted at the discretion of the Board. Options issued under this plan that are deemed to be incentive stock options will be priced at not less than 100 percent of the fair market value of the shares of Common Stock underlying the options at the date of the grant, subject to certain limitations for 10 percent stockholders. The fair value of each option granted was estimated at the time of grant using the Black-Scholes option pricing model.
	All the options granted under the 2012 Plan, vest yearly at the rate of one-third per year, starting on the first year anniversary of the grant date and expire on the fifth anniversary of the grant date. On August 5, 2014, vesting period was amended and all the options are fully vested and exercisable.  The following table summarizes the stock option activities of the Company.
	Outstanding as of November 30, 2012		—
	Granted		100,000
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of  November 30, 2013 and August 31, 2014		100,000
	The share-based compensation for the three and nine months ended August 31, 2014 was $97,970 and $186,022 (three and nine months ended August 31, 2013 - $61,637 and $61,637). The Company recorded this in selling, general and administrative expenses with the corresponding credit to additional paid-in capital.
	As of November 30, 2013 the Company has granted options to purchase a total of 100,000 shares of Common Stock at an exercise price of $3.94 per share, to its four independent directors and chief financial officer, all of which are currently outstanding and are vested and exercisable. All of these outstanding stock options have an exercise price equal to the fair market price on the date of grant. As of November 30, 2013, the total fair value of the options granted to the independent directors and chief financial officer at the respective grant dates was $292,174, of which the unrecognized portion of $186,022 related to the unvested shares associated with these stock option grants will be recognized over a period of three years.
	As of August 31, 2014 the Company has granted a total of 100,000 options to purchase Common Stock to employees, directors and advisory board members, all of which are currently outstanding and fully vested and exercisable. All of these outstanding stock options have an exercise price above the average market price. As of August 31, 2014, the total fair value of the options granted at the respective grant dates was $292,174, all of which has been recognized as fully vested.

14_FAIR_VALUE_MEASUREMENTS_CON

14. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	9 Months Ended
	Aug. 31, 2014
Fair Value Disclosures [Abstract]	'
14. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK	'
	a) The Company's cash and cash equivalents, which are carried at fair values, are classified as a level 1 financial instrument at November 30, 2013 and August 31, 2014.
	b) The Company is exposed to the following concentrations of risk:
	Major Customers
	Two major customers comprised 77% and 72% of total revenue for the three and nine months ended August 31, 2014 (three and nine months ended August 31, 2013 - two major customers comprised 21% and 64% of total revenue).
	As at August 31, 2014, accounts receivable balances of the two major customers were $22,290 and $58,453, respectively (as at August 31, 2013 - $nil and $26,083, respectively).  As at August 31, 2014, customer deposit by the two major customers were $nil and $nil, respectively (as at August 31, 2013 - $115,341 and $nil, respectively).  As at November 30, 2013, accounts receivable balances of the two major customers were $685,986.
	Major Vendors
	The Company has an exclusive agreement to manufacture biodiesel processor equipment with a third party equipment manufacturer. During the three and nine months ended August 31, 2014, the Company made purchases of $nil and $nil (three and nine months ended August 31, 2013 - $nil and $45,893) from this equipment manufacturer. As of November 30, 2013 and August 31, 2014, the Company had accounts payable of $21,856 and $6,837 owing to this equipment manufacturer, respectively.
	The Company’s major purchases of feedstock oil and biodiesel from third parties for the three and nine months ended August 31, 2014 were $2,549,354 and $2,549,354 that consisted of only one new major vendor for feedstock oil (three and nine months ended August 31, 2013 - three major vendors comprising total purchases of $661,625 and $2,228,543).
	As at November 30, 2013, the accounts payable balance to the three major vendors were $1,053,480, $575,043 and $nil.
	As at August 31, 2014, the accounts payable balance from the one new feedstock oil vendor was $91,176.  The three major vendors from fiscal year 2013 were fully paid in the 2014 nine month period (payment included interest incurred on outstanding balance of $97,973).
	Economic and Political Risks
	The Company faces a number of risks and challenges as a result of having primary operations and marketing in Canada and sales in the United States.  Changing political climates in Canada and the United States could have a significant effect on the Company’s business.
	c) The Company's financial instruments are exposed to certain financial risks, including credit risk, currency risk and liquidity risk.
	Credit Risk
	Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's cash and cash equivalents and trade accounts receivable. The Company places its cash and cash equivalents with institutions of high creditworthiness. The carrying value of the financial assets represents the maximum credit exposure.
	The Company minimizes credit risk by routinely reviewing the credit risk of the counterparty to the arrangement and has maintained an allowance for doubtful accounts of $65,662 related to credit risk as at August 31, 2014 (as at November 30, 2013 - $30,000), which is considered adequate.
	Currency Risk
	The Company is exposed to the financial risk related to the fluctuation of foreign exchange rates. The Company's functional currency is U.S. dollars. A significant change in the currency exchange rates between the U.S. dollar relative to the Canadian dollar could have an effect on the Company's results of operations, financial position and cash flows. The Company has not entered into any derivative financial instruments to manage exposures to currency fluctuations.
	Included in selling, general and administrative expenses are foreign currency gains (losses) for the three and nine months ended August 31, 2014 of $2,822 and $33,031 (three and nine months ended August 31, 2013 of $30,120 and $106,079).
	The Canadian dollar balances and exchange differences are as follows:
		CDN$			USD$ Historical			USD –August 31, 2014
	Note 8: Term loan (“July 2013”) - Principal	$	1,600,000		$	1,540,640		$	1,467,360
	Note 8: Term loan (“July 2013”) - Partial payment		(250,000	)		(227,875	)		(225,765	)
	Note 16: Canadian Incentive - Mississauga facility - Total Incentive per Agreement		5,410,000		NA				4,975,577
	Note 16: Canadian Incentive - Sombra facility - Total Incentive per Agreement		14,785,200		NA				13,597,948
	Liquidity Risk
	Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company has a planning and budgeting process in place to help determine the funds required to support the Company's normal operating requirements on an ongoing basis and its expansionary plans. The Company ensures that there are sufficient funds to meet its short-term business requirements, taking into account its anticipated cash flows from operations and its holdings of cash.
	As at August 31, 2014, due in large part to the funds spent to develop and build the Sombra facility as well as minimal sales of biodiesel, the Company had a working capital deficiency of $535,389.
	The Company anticipates that its Sombra facility will generate positive cash flows from operations and will operate profitably once full-scale commercial operations are achieved. In order to meet its development goals and ongoing operational requirements, the Company may require additional financing in the next 12 months. However, management believes that the anticipated positive cash flows from operations, the potential sale of biodiesel equipment and the cash flow from the additional financing completed in August 2014 and the anticipated additional financing will be sufficient to meet the Company’s cash requirements for at least the next 12 months.
	As at August 31, 2014, the Company received customer deposits of $152,186 (November 30, 2013 - $8,185) against potential sale of biodiesel equipment.

15_COMMITMENTS

15. COMMITMENTS	9 Months Ended
	Aug. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
15. COMMITMENTS	'
	Building Leases:
	Methes Canada is a party to a lease agreement for the Mississauga facility and to a sublease agreement for a unit adjacent to its Mississauga facility. On September 28, 2012, the Company re-negotiated and renewed a combined five year lease term for both of these facilities starting from January 1, 2013 to December 31, 2017. The renewed lease term provides for a two month rent free period in 2013.
	As at August 31, 2014, Methes Canada must pay, in addition to other amounts such as it’s pro rata share of taxes, the following amounts over the term of the lease:
			Annual
			Minimum Rent
	2014		$	33,235
	2015		$	132,941
	2016		$	132,941
	2017		$	132,941
	2018		$	11,078
	Railroad Car Leases:
	As at August 31, 2014, the Company is a party to the following lease agreements for railcars at its Sombra facility:
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
	Ten railcars at $8,460 per month	1-May-13		30-Apr-18	60 months
	Ten railcars at $8,510 per month	1-May-13		30-Apr-18	60 months
			Annual
			Minimum Rent
	2014		$	93,180
	2015		$	369,845
	2016		$	359,495
	2017		$	321,240
	2018		$	147,250

16_CONTRIBUTION_AGREEMENTS_WIT

16. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	9 Months Ended
	Aug. 31, 2014
Notes to Financial Statements	'
16. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA	'
	Mississauga Facility:
	In 2009, the Company entered into a Non-Refundable Contribution Agreement with the Minister of Natural Resources of Canada for the Mississauga facility under the ecoENERGY for Biofuels program. Under this agreement, the Company may receive up to $4,975,577 - in the years from 2009 to 2016 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the three and nine months ended August 31, 2014, the Company claimed incentives of $nil and $nil (three and nine months ended August 31, 2013 - $nil and $10,171). Since entering into the program to August 31, 2014, the Company has claimed and received total incentives of $1,485,285.
	Included in accounts receivable as at November 30, 2013 and August 31, 2014, is an amount receivable of $nil and $nil, respectively, due from the Minister of Natural Resources of Canada.
	Sombra Facility:
	In 2010, the Company applied for an incentive under the ecoENERGY for Biofuels program for its Sombra facility and was approved by the Canadian government. The final Contribution Agreement with the Minister of Natural Resources of Canada for the Sombra facility under the ecoENERGY for Biofuels program was signed by the Company and the Canadian Government on December 6, 2011. Under this agreement as amended, the Company may receive up to $13,597,948 - for the years 2012 to 2017 from the Canadian government in biodiesel production incentives when biodiesel is produced and sold. The contribution from the Canadian Government is non-refundable by the Company.
	For the three and nine months ended August 31, 2014, the Company claimed incentives of $179,594 and $218,185 (three and nine months ended August 31, 2013 - $90,470 and $259,303). Since entering into the program to August 31, 2014, the Company has claimed total incentives of $755,060 and has received a total of $575,466.
	Included in accounts receivable as at November 30, 2013 and August 31, 2014, is an amount receivable of $277,573 and $179,594, respectively, due from the Minister of Natural Resources of Canada.

17_SEGMENT_INFORMATION

17. SEGMENT INFORMATION	9 Months Ended
	Aug. 31, 2014
Segment Reporting [Abstract]	'
17. SEGMENT INFORMATION	'
	The Company reports a single operating segment, being a producer and seller of biodiesel fuel and biodiesel processing equipment.
	Geographic segments:
	The Company's assets and operating facilities, other than cash balances of $16,066 at November 30, 2013 and $43,889 at August 31, 2014, are all located in Canada. The Company services the majority of its customers in the United States. The Company derives its revenue geographically as follows:
		Three Months Ended August 31, 2013		Three Months Ended August 31, 2014		Nine months Ended		Nine months Ended
						August 31,		August 31,
						2013		2014
	Revenue
	United States	$	1,510,501	$	2,137,870	$	3,681,634	$	2,708,390
	Canada		236,703		262,777		604,035		510,138
		$	1,747,204	$	2,400,647	$	4,285,669	$	3,218,528

18_INTEREST_EXPENSE

18. INTEREST EXPENSE	9 Months Ended
	Aug. 31, 2014
Banking and Thrift [Abstract]	'
18. INTEREST EXPENSE	'
	Interest expense table as follows:
		Three Months Ended August 31,		Three Months Ended		Nine months Ended		Nine months Ended
		2013		August 31,		August 31,		August 31,
				2014		2013		2014
	Interest accrued on promissory notes	$	46,868	$	43,100	$	116,910	$	127,118
	Interest paid on term loan		66,483		44,250		236,051		131,816
	Interest paid on vendor payables		215		6,401		2,155		123,395
	Financing fees		13,266		3,107		14,685		8,604
	Total expense	$	126,832		$96,858	$	369,801	$	390,933

19_SUBSEQUENT_EVENTS

19. SUBSEQUENT EVENTS	9 Months Ended
	Aug. 31, 2014
Subsequent Events [Abstract]	'
19. SUBSEQUENT EVENTS	'
	On September 18, 2014, Methes Canada signed a term sheet with a new lender providing for $1,700,000 CAD mortgage loan, which will be used to repay the outstanding balance on the July 2013 Facility (the “September 2014 Loan”). The salient terms of the September 2014 Loan include, but are not limited to 24 months term, an interest rate of 12.5% per annum, payable monthly, and the outstanding principal due at maturity. The September 2014 Loan will be collateralized by a security agreement from Methes Canada on certain of its assets, a first collateral mortgage on its real property located at Sombra, Ontario, a promissory note in the amount of $1,700,000 CAD, and a guarantee of repayment by the Company.

2_SUMMARY_OF_SIGNIFICANT_ACCOU1

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Aug. 31, 2014
Accounting Policies [Abstract]	'
Basis of Consolidation	'
	Basis of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries Methes Canada and Methes USA.  All significant inter-company transactions and balances have been eliminated.
Deferred Financing Fees	'
	Deferred Financing Fees
	Financing fees relating to other financing arrangements are deferred and amortized over the term of the respective loan.
Shipping and Handling Costs	'
	Shipping and Handling Costs
	The Company accounts for shipping and handling fees in accordance with FASB ASC 705 "Cost of Sales and Services". Shipping and handling costs for the three and nine months ended August 31, 2014 were $96,362 and $119,965, respectively (three and nine months ended August 31, 2013 was $23,869 and $199,125, respectively. Costs related to raw materials purchased, are included in inventory or cost of goods sold, as appropriate. While amounts charged to customers for shipping product are included in revenues, the related outbound freight costs are included in expenses as incurred.
Income Taxes and Uncertain Tax Positions	'
	Income Taxes and Uncertain Tax Positions
	The Company accounts for income taxes under ASC 740 Accounting for Income Taxes. Under ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the periods in which those temporary differences are expected to be recovered or settled. Under ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. ASC 740-10-05, Accounting for Uncertainty in Income Taxes, prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return.
	For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
	The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. Potential tax benefits from net operating losses and foreign tax credit carry forwards are not recognized by the Company until their realization is more likely than not. The Company assesses the validity of conclusions regarding uncertain tax positions on a quarterly basis to determine if facts or circumstances have arisen that might cause the Company to change their judgment regarding the likelihood of a tax position's sustainability under audit. The Company has determined that there were no material uncertain tax positions as at November 30, 2013 and August 31, 2014.
Per Share Data	'
	Per Share Data
	Basic earnings per share ("EPS") is determined by dividing net earnings available to common stockholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. In computing diluted EPS, the average number of shares of Common Stock outstanding is increased by Common Stock options and warrants outstanding if the exercise prices were lower than the average market price of Common Stocks using the treasury stock method. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. Potentially dilutive shares include 2,192,012 warrants and 365,057 Common Stock options issued and outstanding as at August 31, 2013 and 3,923,149 warrants, 445,071 Common Stock options and 111,822 shares of Preferred Stock issued and outstanding as at August 31, 2014. All outstanding warrants, preferred shares and options have an anti-dilutive effect on the loss per share and are therefore excluded from the determination of the diluted loss per share calculation for the three and nine months ended August 31, 2013 and August 31, 2014.
Renewable Identification Numbers (RINs)	'
	Renewable Identification Numbers (RINs)
	When the Company imports and sells a gallon of biodiesel into United States, 1.5 RINs per gallon are generated. RINs are used to track compliance with Renewable Fuel Standards (RFS2). RFS2 allows the Company to attach between zero and 2.5 RINs to any gallon of biodiesel. When the Company imports and sells a gallon of biodiesel, 1.5 RINs are generally attached. As a result, a portion of the selling price for a gallon of biodiesel is generally attributable to RFS2 compliance. However, RINs that the Company generates are a form of government incentive and not a result of the physical attributes of the biodiesel production. Therefore, no cost is allocated to the RIN when it is generated, regardless of whether the RIN is transferred with the biodiesel produced or held by the Company pending attachment to other biodiesel production sales.
	The Company may, however, obtain RINs returned from its customers as part of the biodiesel sales terms after having separated the RINs from gallons of biomass-based diesel. From time to time, the Company holds varying amounts of these separated RINs for resale. RINs obtained from customers are initially recorded at fair value on the date received, and are subsequently revalued at fair value as of the last day of each accounting period. Fair value adjustments are reflected in costs of goods sold for the period. The value of RINs obtained from customers are reflected in “Inventories” on the consolidated balance sheet.
Derivative Instruments	'
	Derivative Instruments
	Derivatives are recorded on the balance sheet at fair value with changes in fair value recognized in current period earnings. The Company accounts for derivative instruments under ASC Topic 815 - 40, “Derivatives and Hedging” or ASC 815 - 40. Under these standards, derivative instruments are recognized as either assets or liabilities in the balance sheet and are measured at fair value. The Company utilizes futures contracts and options to hedge feedstock purchases. The Company has designated the derivatives as non-hedge derivatives that are utilized to manage cash flow. Unrealized gains and losses on the futures contracts and options are therefore recognized as a component of biodiesel cost of goods sold, and are reflected in current results of operations.
New Accounting Pronouncements	'
	New Accounting Pronouncements
	In December 2011, the FASB issued ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities (Topic 210). The new disclosure requirements mandate that entities disclose both gross and net information about instruments and transactions eligible for offset in the statement of financial position as well as instruments and transactions subject to an agreement similar to a master netting arrangement. In addition, the standard requires disclosure of collateral received and posted in connection with master netting agreements or similar arrangements. The amendments are effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The disclosures required by the amendments are required to be applied retrospectively for all comparative periods presented. The Company adopted this statement effective December 1, 2013. The adoption of this statement did not have a material effect on the Company’s unaudited condensed consolidated financial statements.
	On May 28, 2014, the FASB issued a new financial accounting standard on revenue from contracts with customers, Update No. 2014-09, Revenue from Contracts with Customers (Topic 606). The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard.
	On August 27, 2014, the FASB issued a new financial accounting standard on going concern, Update 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The standard provides guidance about management’s responsibility to evaluate whether there is substantial doubt about the organization’s ability to continue as a going concern. The amendments in this Update apply to all companies. They become effective in the annual period ending after December 15, 2016, with early application permitted. The Company is currently evaluating the impact of this accounting standard.
	All other recent pronouncements issued by the FASB or other authoritative standards groups with future effective dates are either not applicable or are not expected to be significant to the condensed consolidated financial statements of the Company.

4_INVENTORIES_Tables

4. INVENTORIES (Tables)	9 Months Ended
	Aug. 31, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventories	'
		As at		As at
		November 30,		August 31,
		2013		2014
	Raw materials	$	345,049	$	194,974
	Finished goods		444,648		541,558
	Equipment		11,366		11,366
	K2 RINs		—		102,834
		$	801,063	$	850,732

6_PROPERTY_PLANT_AND_EQUIPMENT1

6. PROPERTY, PLANT AND EQUIPMENT (Tables)	9 Months Ended
	Aug. 31, 2014
Property, Plant and Equipment [Abstract]	'
Schedule of Property, Plant and Equipment	'
		As at August 31, 2014						As at
								November 30,
								2013
		Cost		Accumulated		Net Book		Net Book
				Depreciation		Value		Value
	Sombra site:
	Land	$	409,134	$	—	$	409,134	$	409,134
	Building		2,944,356		297,116		2,647,240		2,702,446
	Equipment		775,865		465,848		310,017		390,465
	Equipment - Denami 3000		4,254,995		316,489		3,938,506		3,975,441
	Computer equipment		11,835		10,282		1,553		5,918
	Vehicle		11,622		1,162		10,460		11,331
	Mississauga site:
	Computer equipment		23,464		23,403		61		1,316
	Leasehold improvements		102,201		63,403		38,798		46,591
	Equipment and fixtures		255,463		197,434		58,029		77,662
	Equipment - Denami 600		720,042		183,253		536,789		558,390
		$	9,508,977	$	1,558,390	$	7,950,587	$	8,178,694

7_PAYABLE_TO_RELATED_PARTIES_A1

7. PAYABLE TO RELATED PARTIES AND OTHERS (Tables)	9 Months Ended
	Aug. 31, 2014
Payable To Related Parties And Others Tables	'
Schedule of Payables to related parties	'
		As at		As at
		November 30,		August 31,
		2013		2014
	Michel G. Laporte (stockholder and Director)  (reclassified to non-current, see note 9)	$	719,230	$	—
	Due to an unrelated corporation (reclassified to non-current, see note 10)		1,495,477		—
	Other loan		36,695		—
		$	2,251,402	$	—

8_SHORTTERM_LOANS_Tables

8. SHORT-TERM LOANS (Tables)	9 Months Ended
	Aug. 31, 2014
Short-Term Loans Tables	'
Short-term loans	'
		As at		Interest Accrued		Repayments		Foreign Exchange Adjustments		As at
		November 30,								August 31,
		2013								2014
	Term loan (July 2013)	$	1,506,560	$	—	$	-227,875	$	-37,090	$	1,241,595
	Promissory note (i)		52,533		2,400		—		—		54,933
	Promissory note (ii)		402,558		4,099		-397,400		-9,257		—
		$	1,961,651	$	6,499	$	-625,275	$	-46,347	$	1,296,528

12_STOCKHOLDERS_EQUITY_Tables

12. STOCKHOLDERS' EQUITY (Tables)	9 Months Ended
	Aug. 31, 2014
Stockholders Equity Tables	'
Common stock	'
			No. of Shares			Price per Share
	Common Stock
	Balance as at November 30, 2013			7,231,417
	Issuance of shares under private placement			1,081,161		$	2
	Issuance of shares under public offering			2,800,000		$	2
	Issuance of shares upon conversion of Preferred Stocks units			148,960		$	2.26
	Issuance of shares upon conversion of accrued dividends on Preferred Stocks units			7,205		$	2.26
	Issuance of shares for cash			16,129		See below
	Issuance of shares for services			133,871		See below
	Issuance of shares for loan settlement			34,688		$	3.69
	Issuance of shares upon conversion of Placement Agent Warrant			7,000		$	2
	Balance as at August 31, 2014			11,460,431
Stock warrant table	'
		Grant Date		Exercise Period	No of Warrants			Exercise Price per share		Fair Value of Broker Warrants
	Balance as at November 30, 2013					2,678,872
	Common Stock Warrants issued – Private Placement	Dec. 20, 2013		5 years from grant date		1,081,161		$	4
	Placement Agent Warrant – Private Placement	Dec. 20 2013		5 years from grant date		108,116		$	2	$	257,553
	Placement Agent Warrant – Private Placement (November 27, 2013)	Dec. 20 2013		5 years from grant date		5,000		$	2	$	6,403
	Common Stock Warrant issued-accredited investor	Jan. 10, 2014		5 years from grant date		50,000		$	4
	Placement Agent Warrant exercise					-7,000		$	2
	Common Stock Warrant issued upon exercise of Placement Agent Warrant	May 9 and 14, 2014				7,000		$	4
				Dec. 20, 2018
	Balance as at August 31, 2014					3,923,149

13_STOCKBASED_COMPENSATION_Tab

13. STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Aug. 31, 2014
2012 Option Plan	'
Stock option activities	'
	Outstanding as of November 30, 2012		—
	Granted		100,000
	Exercised		—
	Cancelled/forfeited		—
	Outstanding as of  November 30, 2013 and August 31, 2014		100,000
2008 Directors, Officers and Employees Stock Option Plan	'
Stock option activities	'
		Number of options
	Outstanding as of November 30, 2012		383,310
	Granted		10,000
	Exercised		—
	Cancelled/forfeited		-27,379
	Outstanding as of November 30, 2013		365,931
	Granted		—
	Exercised		—
	Cancelled/forfeited		-20,860
	Outstanding as of August 31, 2014		345,071

14_FAIR_VALUE_MEASUREMENTS_CON1

14. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK (Tables)	9 Months Ended
	Aug. 31, 2014
Fair Value Measurements Concentrations And Risk Tables	'
Schedule of exchange differences	'
		CDN$			USD$ Historical			USD –August 31, 2014
	Note 8: Term loan (“July 2013”) - Principal	$	1,600,000		$	1,540,640		$	1,467,360
	Note 8: Term loan (“July 2013”) - Partial payment		(250,000	)		(227,875	)		(225,765	)
	Note 16: Canadian Incentive - Mississauga facility - Total Incentive per Agreement		5,410,000		NA				4,975,577
	Note 16: Canadian Incentive - Sombra facility - Total Incentive per Agreement		14,785,200		NA				13,597,948

15_COMMITMENTS_Tables

15. COMMITMENTS (Tables)	9 Months Ended
	Aug. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Annual Minimum Rent	'
			Annual
			Minimum Rent
	2014		$	33,235
	2015		$	132,941
	2016		$	132,941
	2017		$	132,941
	2018		$	11,078
Schedule of lease agreements	'
	As at August 31, 2014, the Company is a party to the following lease agreements for railcars at its Sombra facility:
		Start Date		End Date	Term
	Four railcars at $3,100 per month	1-Aug-13		31-Jul-18	60 months
	Four railcars at $3,100 per month	1-Apr-13		31-Mar-18	60 months
	Four railcars at $ 3,600 per month	1-Jul-13		30-Jun-18	60 months
	Four railcars at $3,140  per month	1-Dec-11		30-Nov-16	60 months
	One railcar at $575 per month	1-Jan-12		31-Dec-16	60 months
	One railcar at $575 per month	1-May-12		30-Jun-15	36 months
	Ten railcars at $8,460 per month	1-May-13		30-Apr-18	60 months
	Ten railcars at $8,510 per month	1-May-13		30-Apr-18	60 months
			Annual
			Minimum Rent
	2014		$	93,180
	2015		$	369,845
	2016		$	359,495
	2017		$	321,240
	2018		$	147,250

17_SEGMENT_INFORMATION_Tables

17. SEGMENT INFORMATION (Tables)	9 Months Ended
	Aug. 31, 2014
Segment Reporting [Abstract]	'
Schedule of Revenue Geographically	'
		Three Months Ended August 31, 2013		Three Months Ended August 31, 2014		Nine months Ended		Nine months Ended
						August 31,		August 31,
						2013		2014
	Revenue
	United States	$	1,510,501	$	2,137,870	$	3,681,634	$	2,708,390
	Canada		236,703		262,777		604,035		510,138
		$	1,747,204	$	2,400,647	$	4,285,669	$	3,218,528

18_INTEREST_EXPENSE_Tables

18. INTEREST EXPENSE (Tables)	9 Months Ended
	Aug. 31, 2014
Banking and Thrift [Abstract]	'
Interest Expense Table	'
	Interest expense table as follows:
		Three Months Ended August 31,		Three Months Ended		Nine months Ended		Nine months Ended
		2013		August 31,		August 31,		August 31,
				2014		2013		2014
	Interest accrued on promissory notes	$	46,868	$	43,100	$	116,910	$	127,118
	Interest paid on term loan		66,483		44,250		236,051		131,816
	Interest paid on vendor payables		215		6,401		2,155		123,395
	Financing fees		13,266		3,107		14,685		8,604
	Total expense	$	126,832		$96,858	$	369,801	$	390,933

1_BASIS_OF_PRESENTATION_AND_NA

1. BASIS OF PRESENTATION AND NATURE OF THE BUSINESS (Details Narrative) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013	Nov. 30, 2013
Basis Of Presentation And Nature Of Business Details Narrative	'	'	'	'	'
Working capital deficiency	($535,389)	'	($535,389)	'	'
Loss incurred	-2,031,094	-1,319,748	-5,079,380	-4,202,891	-5,651,665
Net cash used in operating activities	'	'	($5,107,730)	($1,996,216)	'

2_SUMMARY_OF_SIGNIFICANT_ACCOU2

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013
Shipping and handling costs	$96,362	$23,869	$119,965	$199,125
Preferred Stock	'	'	'	'
Anti-dilutive securities excluded from earnings calculations	'	'	111,822	'
Warrants	'	'	'	'
Anti-dilutive securities excluded from earnings calculations	'	'	3,923,149	2,192,012
Stock Options	'	'	'	'
Anti-dilutive securities excluded from earnings calculations	'	'	445,071	365,057

4_INVENTORIES_Details

4. INVENTORIES (Details) (USD $)	Aug. 31, 2014	Nov. 30, 2013
Inventories Details	'	'
Raw materials	$194,974	$345,049
Finished goods	541,558	444,648
Equipment	11,366	11,366
K2 RINs	102,834	0
Inventory, Total	$850,732	$801,063

6_PROPERTY_PLANT_AND_EQUIPMENT2

6. PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	Aug. 31, 2014	Nov. 30, 2013
Cost	$9,508,977	'
Accumulated Depreciation	1,558,390	'
Property Plant and Equipment, Net	7,950,587	8,178,694
Sombra site | Land	'	'
Cost	409,134	'
Accumulated Depreciation	0	'
Property Plant and Equipment, Net	409,134	409,134
Sombra site | Building	'	'
Cost	2,944,356	'
Accumulated Depreciation	297,116	'
Property Plant and Equipment, Net	2,647,240	2,702,446
Sombra site | Equipment	'	'
Cost	775,865	'
Accumulated Depreciation	465,848	'
Property Plant and Equipment, Net	310,017	390,465
Sombra site | Equipment - Denami 3000	'	'
Cost	4,254,995	'
Accumulated Depreciation	316,489	'
Property Plant and Equipment, Net	3,938,506	3,975,441
Sombra site | Computer Equipment	'	'
Cost	11,835	'
Accumulated Depreciation	10,282	'
Property Plant and Equipment, Net	1,553	5,918
Sombra site | Vehicle	'	'
Cost	11,622	'
Accumulated Depreciation	1,162	'
Property Plant and Equipment, Net	10,460	11,331
Mississauga site | Computer Equipment	'	'
Cost	23,464	'
Accumulated Depreciation	23,403	'
Property Plant and Equipment, Net	61	1,316
Mississauga site | Leasehold Improvements	'	'
Cost	102,201	'
Accumulated Depreciation	63,403	'
Property Plant and Equipment, Net	38,798	46,591
Mississauga site | Equipment and fixtures	'	'
Cost	255,463	'
Accumulated Depreciation	197,434	'
Property Plant and Equipment, Net	58,029	77,662
Mississauga site | Equipment - Denami 600	'	'
Cost	720,042	'
Accumulated Depreciation	183,253	'
Property Plant and Equipment, Net	$536,789	$558,390

6_PROPERTY_PLANT_AND_EQUIPMENT3

6. PROPERTY, PLANT AND EQUIPMENT (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013
Property Plant And Equipment Details Narrative	'	'	'	'
Depreciation Expense	$106,039	$104,743	$318,134	$338,335

7_PAYABLE_TO_RELATED_PARTIES_D

7. PAYABLE TO RELATED PARTIES (Details) (USD $)	Aug. 31, 2014	Nov. 30, 2013
Payable To Related Parties Details	'	'
Michel G. Laporte (shareholder and Director)	$0	$719,230
Due to an unrelated corporation (reclassified to non-current, see note 10)	0	1,495,477
Other loan	0	36,695
Payable to Related Parties, Total	$0	$2,251,402

8_SHORTTERM_LOANS_Details

8. SHORT-TERM LOANS (Details) (USD $)	9 Months Ended
	Aug. 31, 2014
Beginning Balance	$1,961,651
Advances	6,499
Repayments	-625,275
Foreign Exchange Adjustments	-46,347
Ending Balance	1,296,528
Term loan (July 2013)	'
Beginning Balance	1,506,560
Advances	0
Repayments	-227,875
Foreign Exchange Adjustments	-37,090
Ending Balance	1,241,595
Promissory note (i)	'
Beginning Balance	52,533
Advances	2,400
Repayments	0
Foreign Exchange Adjustments	0
Ending Balance	54,933
Promissory note (ii)	'
Beginning Balance	402,558
Advances	4,099
Repayments	-397,400
Foreign Exchange Adjustments	-9,257
Ending Balance	$0

12_STOCKHOLDERS_EQUITY_Details

12. STOCKHOLDERS' EQUITY (Details) (USD $)	9 Months Ended
	Aug. 31, 2014
Beginning Balance, Shares	7,231,417
Ending Balance, Shares	11,460,431
Private Placement	'
Stock issued	1,081,161
Issued, price per share	2
Public Offering	'
Stock issued	2,800,000
Issued, price per share	2
Conversion of Preferred Stocks units	'
Stock issued	148,960
Issued, price per share	2.26
Conversion of accrued dividends on Preferred Stocks units	'
Stock issued	7,205
Issued, price per share	2.26
Issuance of shares for cash	'
Stock issued	16,129
Issuance of shares for services	'
Stock issued	133,871
Issuance of shares for loan settlement	'
Stock issued	34,688
Issued, price per share	3.69
Issuance of shares upon conversion of Placement Agent Warrant	'
Stock issued	7,000
Issued, price per share	2

12_STOCKHOLDERS_EQUITY_Details1

12. STOCKHOLDERS' EQUITY (Details 1) (USD $)	9 Months Ended
	Aug. 31, 2014
Balance beginning of period	2,678,872
Balance end of period	3,923,149
Common Stock Warrants issued Private Placement	'
Grant Date	'Dec. 20, 2013
Exercise Period	'5 years
Number of Warrants	1,081,161
Exercise Price per share	4
Placement Agent Warrant Private Placement	'
Grant Date	'Dec. 20, 2013
Exercise Period	'5 years
Number of Warrants	108,116
Exercise Price per share	2
Fair Value of Broker Warrants	257,553
Placement Agent Warrant Private Placement (November 27, 2013)	'
Grant Date	'Dec. 20, 2013
Exercise Period	'5 years
Number of Warrants	5,000
Exercise Price per share	2
Fair Value of Broker Warrants	6,403
Common Stock Warrant issued-accredited investor	'
Grant Date	'Jan. 10, 2014
Exercise Period	'5 years
Number of Warrants	50,000
Exercise Price per share	4
Placement Agent Warrant exercise	'
Number of Warrants	-7,000
Exercise Price per share	2
Common Stock Warrant issued upon exercise of Placement Agent Warrant	'
Grant Date	'May 9 and 14, 2014
Exercise Period Date	'December 20, 2018
Number of Warrants	7,000
Exercise Price per share	4

13_STOCKBASED_COMPENSATION_Det

13. STOCK-BASED COMPENSATION (Details )	9 Months Ended	12 Months Ended
	Aug. 31, 2014	Nov. 30, 2013
2008 Option Plan	'	'
Number of Options Outstanding, Beginning	365,931	383,310
Number of Options Granted	0	10,000
Number of Options Exercised	0	0
Number of Options Canceled/Forfeited	-20,860	-27,379
Number of Options, Ending	345,071	365,931
2012 Option Plan	'	'
Number of Options Outstanding, Beginning	100,000	0
Number of Options Granted	0	100,000
Number of Options Exercised	0	0
Number of Options Canceled/Forfeited	0	0
Number of Options, Ending	100,000	100,000

14_FAIR_VALUE_MEASUREMENTS_CON2

14. FAIR VALUE MEASUREMENTS, CONCENTRATIONS AND RISK (Details) (USD $)	9 Months Ended
	Aug. 31, 2014
Term loan	$1,467,360
Term loan - Partial payment	-225,765
Mississauga site	'
Term loan - Partial payment	4,975,577
Sombra site	'
Term loan - Partial payment	13,597,948
CDN	'
Term loan	1,600,000
Term loan - Partial payment	-250,000
CDN | Mississauga site	'
Term loan - Partial payment	5,410,000
CDN | Sombra site	'
Term loan - Partial payment	14,785,200
USD Historical	'
Term loan	1,540,640
Term loan - Partial payment	($227,875)

15_COMMITMENTS_Details

15. COMMITMENTS (Details) (USD $)	Aug. 31, 2014
Mississauga Facility	'
2014	$33,235
2015	132,941
2016	132,941
2017	132,941
2018	11,078
Sombra Facility	'
2014	93,180
2015	369,845
2016	359,495
2017	321,240
2018	$147,250

15_COMMITMENTS_Details_1

15. COMMITMENTS (Details 1)	9 Months Ended
	Aug. 31, 2014
Agreement 1	'
Start Date	'2013-08-01
End Date	'2018-07-31
Term	'60 months
Agreement 2	'
Start Date	'2013-04-01
End Date	'2018-03-31
Term	'60 months
Agreement 3	'
Start Date	'2013-07-01
End Date	'2018-06-30
Term	'60 months
Agreement 4	'
Start Date	'2011-12-01
End Date	'2016-11-30
Term	'60 months
Agreement 5	'
Start Date	'2012-01-01
End Date	'2016-12-31
Term	'60 months
Agreement 6	'
Start Date	'2012-05-01
End Date	'2015-06-30
Term	'36 months
Agreement 7	'
Start Date	'2013-05-01
End Date	'2018-04-30
Term	'60 months
Agreement 8	'
Start Date	'2013-05-01
End Date	'2018-04-30
Term	'60 months

16_CONTRIBUTION_AGREEMENTS_WIT1

16. CONTRIBUTION AGREEMENTS WITH MINISTER OF NATURAL RESOURCES OF CANADA (Details Narrative) (USD $)	3 Months Ended		9 Months Ended		65 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014
Mississauga site	'	'	'	'	'
Incentives	$0	$0	$0	$10,171	$1,485,285
Sombra site	'	'	'	'	'
Incentives	$179,594	$90,470	$218,185	$259,303	$755,060

17_SEGMENT_INFORMATION_Details

17. SEGMENT INFORMATION (Details) (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013
Revenue	'	'	'	'
Revenue	$2,400,647	$1,747,204	$3,218,528	$4,285,669
United States	'	'	'	'
Revenue	'	'	'	'
Revenue	2,137,870	1,510,501	2,708,390	3,681,634
Canada	'	'	'	'
Revenue	'	'	'	'
Revenue	$262,777	$236,703	$510,138	$604,035

18_INTEREST_EXPENSE_Details

18. INTEREST EXPENSE (Details) (USD $)	3 Months Ended		9 Months Ended
	Aug. 31, 2014	Aug. 31, 2013	Aug. 31, 2014	Aug. 31, 2013
Financing fees	$3,107	$13,266	$8,604	$14,685
Total expense	96,858	126,832	390,933	369,801
Promissory notes	'	'	'	'
Interest expense	43,100	46,868	127,118	116,910
Term loan	'	'	'	'
Interest expense	44,250	66,483	131,816	236,051
Vendor payables	'	'	'	'
Interest expense	$6,401	$215	$123,395	$2,155